1st Quarter - Report · 2026

Filing UUID: 5442beda-ef83-4855-ac74-94aaca6cf92d
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-18 14:06:44
Income (reported): $60,000
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

W STRATEGIES, LLC

Government Affairs Consulting Firm.

Contact: DARREN WILLCOX
Phone: +1 202-494-6268
Address: zip:20004, city:Washington, state:DC, street:1455 Pennsylvania Avenue, NW Suite 400

Client

INCYTE CORPORATION

â€‹Biopharmaceutical Company.

State: DE
Country: US
Government-entity client: false
Effective date: 2019-11-11

Issues lobbied + lobbyists

`HCR` — Health Issues

Education around access to innovative therapies in dermatology.

Lobbyists: DARREN WILLCOX

Government entities lobbied: HOUSE OF REPRESENTATIVES

`MMM` — Medicare/Medicaid

Issues related to Medicaid Drug Rebate program rule. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act. Issues related to drug pricing.

Lobbyists: DARREN WILLCOX

Government entities lobbied: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.